Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia
Е. Л. Насонов(Sechenov University), А. I. Zagrebneva(Pirogov Russian National Research Medical University), А. М. Лила, Б. С. Белов(Association of Rheumatologists of Russia), O. A. Nikitinskaya, Д. И. Абдулганиева(Kazan State Medical University), А. Е. Каратеев, А. А. Баранов(Yaroslavl State Medical Academy), Sergey Moiseev(VA Nasonova Scientific Research Institute of Rheumatology), Т. В. Дубинина, Mazurov Vi(North-Western State Medical University named after I.I. Mechnikov)
Cited by 54
Related Papers
RATIONAL USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS. CLINICAL GUIDELINES
|Rheumatology Science and Practice|2018|151
Federal clinical guidelines for diagnosis, treatment and prevention of osteoporosis
|Osteoporosis and Bone Diseases|2021|110
Russian federal clinical guidelines on the diagnostics, treatment, and prevention of osteoporosis
|Problems of Endocrinology|2018|101
Clinical guidelines «Rational use of nonsteroidal anti-inflammatory drugs (NSAIDs) in clinical practice»
|Modern Rheumatology Journal|2015|86
GENERAL PRINCIPLES OF TREATMENT FOR MUSCULOSKELETAL PAIN: INTERDISCIPLINARY CONSENSUS
|Rheumatology Science and Practice (Nauchno-prakticheskaya revmatologiya) (IMA Press)|2016|62